Patent intelligence · US
US 12097264
Methods and compositions for theranostic nanoparticles
Methods and compositions for theranostic nanoparticles
Patent details — US 12097264
- Jurisdiction
- US
- Status
- granted
- Grant date
- Sep 24, 2024
- Expiration
- Sep 19, 2044
- Claims
- 9
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K45/06
Quick answer
US 12097264 (Methods and compositions for theranostic nanoparticles) is held by Sanford Burnham Prebys Medical Discovery Institute at Lake Nona. Status: granted. Granted Sep 24, 2024. Expires Sep 19, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Grant date
- Expiration
- Claims
- 9
- CPC classes
- A61K, A61K38/08, A61K38/10, A61K45/06, A61K47/6869, A61K47/6935
More from Sanford Burnham Prebys Medical Discovery Institute at Lake Nona
Related pharmaceutical patents in our USPTO index.
-
US 12427173
Use of bacteria, bacterial products, and other immunoregulatory entities in combination with anti-CTLA-4 and/or anti-PD-1 antibodies to treat solid tumor malignancies
granted -
US 12428415
Matriptase 2 inhibitors and uses thereof
granted -
US 12421236
Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor
granted -
US 12420085
Synergistic therapies for inter vertebral disc degeneration
granted -
US 12421231
Azaindole derivatives and their use as ERK kinase inhibitors
granted -
US 12403069
Adapter for use in a planetary mixer
granted -
US 12398179
Nanomolar peptides and derivatives to differentially modulate ephrin receptors
granted -
US 12396924
Adapter for use in a planetary mixer
granted
Frequently asked questions
What is US patent 12097264?
US 12097264 (Methods and compositions for theranostic nanoparticles) is held by Sanford Burnham Prebys Medical Discovery Institute at Lake Nona. Status: granted. Granted Sep 24, 2024. Expires Sep 19, 2044 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12097264?
Sanford Burnham Prebys Medical Discovery Institute at Lake Nona is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 706 pharmaceutical patents for this assignee.
When does US 12097264 expire?
Our index shows an expiration date of Sep 19, 2044 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.